Dimitriou, F., Orloff, M. M., Koch Hein, E. C., Cheng, P. F., Hughes, I. F., Simeone, E., Montazeri, K., Grover, P., Mehmi, I., Gerard, C. L., Gaudy-Marqueste, C., Grob, J.-J., Michielin, O., Hamid, O., Long, G. V., Sullivan, R., Kapiteijn, E., Johnson, D. B., Ascierto, P. A., … Dummer, R. (2025). Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors. European Journal of Cancer, 214, 115161. https://doi.org/10.1016/j.ejca.2024.115161
Columbia Affiliation:
Subjects:
Uveal Neoplasms
(MeSH)
Melanoma
(MeSH)
Immune Checkpoint Inhibitors
(MeSH)
Mutation
(MeSH)
Ocular Cancer Research and Treatment
(OpenAlex Topic)
Immunobiology of Dendritic Cells
(OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1016/j.ejca.2024.115161
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex